Sign Up for a Free Account
  • Updated 05.23.2023
  • Released 03.13.2015
  • Expires For CME 05.23.2026

Multiple sclerosis and fertility



Key points

• Multiple sclerosis predominantly affects women in their childbearing years, and fertility is a frequent concern for these patients.

• Infertility is not considered to be more prevalent in patients with multiple sclerosis.

• Fertility in patients with multiple sclerosis can be affected by different factors, including medication side effects and sexual dysfunction.

Historical note and terminology

Multiple sclerosis primarily affects women of childbearing age, and the prevalence of this disease has steadily increased in women over the last five decades, with a woman to man ratio of approximately 3:1. This trend starts in adolescence and continues up to the sixth decade of life, when the ratio decreases to around 2:1 (22). Over the past 30 years, there has been a clear shift in the treatment paradigm of multiple sclerosis in pregnant women and those trying to conceive. Decades ago, physicians believed that pregnancy could worsen the natural course of the disease, as it does some other autoimmune illnesses like systemic lupus erythematosus. The 1998 landmark study Pregnancy in Multiple Sclerosis (PRIMS) provided evidence that contradicted the long-held belief that pregnancy was not safe in multiple sclerosis. This large prospective trial was the first to demonstrate an overall decrease in relapse rate during pregnancy, especially in the third trimester, when compared to the year before pregnancy occurred. It simultaneously raised awareness that there can be increased disease activity in the first 3 to 4 months postpartum. Pregnancy is now widely considered an immune system “tolerant” period for multiple sclerosis patients and some data may even suggest a beneficial effect.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660



ISSN: 2831-9125